TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T15931 XX ID T15931 XX DT 30.05.2008 (created); ane. DT 16.10.2014 (updated); spk. CO Copyright (C), QIAGEN. XX FA STAT1{pY701} XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX IN T09920 CREB1; Mammalia. XX BS R27468. BS R29885. XX DR TRANSPATH: MO000128409. DR TRANSCOMPEL: C00469. XX RN [1]; RE0031906. RX PUBMED: 15012602. RA Auernhammer C. J., Dorn F., Vlotides G., Hengge S., Kopp F. B., Spoettl G., Cengic N., Engelhardt D., Weber M. M. RT The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cells. RL J. Endocrinol. 180:479-86 (2004). RN [2]; RE0053124. RX PUBMED: 17540171. RA Liu B., Yang Y., Chernishof V., Loo R. R., Jang H., Tahk S., Yang R., Mink S., Shultz D., Bellone C. J., Loo J. A., Shuai K. RT Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. RL Cell 129:903-914 (2007). RN [3]; RE0053327. RX PUBMED: 15923602. RA Proietti C., Salatino M., Rosemblit C., Carnevale R., Pecci A., Kornblihtt A. R., Molinolo A. A., Frahm I., Charreau E. H., Schillaci R., Elizalde P. V. RT Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. RL Mol. Cell. Biol. 25:4826-4840 (2005). RN [4]; RE0055059. RX PUBMED: 16858407. RA Johnsen I. B., Nguyen T. T., Ringdal M., Tryggestad A. M., Bakke O., Lien E., Espevik T., Anthonsen M. W. RT Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. RL EMBO J. 25:3335-3346 (2006). RN [5]; RE0063497. RX PUBMED: 18192275. RA Bai Y., Ahmad U., Wang Y., Li J. H., Choy J. C., Kim R. W., Kirkiles-Smith N., Maher S. E., Karras J. G., Bennett C. F., Bothwell A. L., Pober J. S., Tellides G. RT Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation. RL J. Biol. Chem. 283:6832-6842 (2008). RN [6]; RE0063709. RX PUBMED: 18641358. RA Fielding C. A., McLoughlin R. M., McLeod L., Colmont C. S., Najdovska M., Grail D., Ernst M., Jones S. A., Topley N., Jenkins B. J. RT IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. RL J. Immunol. 181:2189-2195 (2008). RN [7]; RE0064533. RX PUBMED: 14976215. RA Nishiya T., DeFranco A. L. RT Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. RL J. Biol. Chem. 279:19008-19017 (2004). RN [8]; RE0065065. RX PUBMED: 15604419. RA Huang A., Zhang Y. Y., Chen K., Hatakeyama K., Keaney JF J. r. RT Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3. RL Circ. Res. 96:164-171 (2005). RN [9]; RE0065138. RX PUBMED: 16710296. RA Malakhova O. A., Kim K. I., Luo J. K., Zou W., Kumar K. G., Fuchs S. Y., Shuai K., Zhang D. E. RT UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. RL EMBO J. 25:2358-2367 (2006). RN [10]; RE0065331. RX PUBMED: 19542364. RA Tsai C. C., Kai J. I., Huang W. C., Wang C. Y., Wang Y., Chen C. L., Fang Y. T., Lin Y. S., Anderson R., Chen S. H., Tsao C. W., Lin C. F. RT Glycogen synthase kinase-3beta facilitates IFN-gamma-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. RL J. Immunol. 183:856-864 (2009). RN [11]; RE0065384. RX PUBMED: 15930175. RA Hogan J. C., Stephens J. M. RT Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. RL J. Endocrinol. 185:485-496 (2005). RN [12]; RE0065994. RX PUBMED: 15166220. RA Dumoutier L., Tounsi A., Michiels T., Sommereyns C., Kotenko S. V., Renauld J. C. RT Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. RL J. Biol. Chem. 279:32269-32274 (2004). RN [13]; RE0067038. RX PUBMED: 20400504. RA Fletcher T. C., DiGiandomenico A., Hawiger J. RT Extended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3. RL J. Biol. Chem. 285:18727-18736 (2010). RN [14]; RE0067449. RX PUBMED: 16096272. RA Zvonic S., Baugh JE J. r., Arbour-Reily P., Mynatt R. L., Stephens J. M. RT Cross-talk among gp130 cytokines in adipocytes. RL J. Biol. Chem. 280:33856-33863 (2005). RN [15]; RE0067754. RX PUBMED: 20051625. RA Walker E. C., McGregor N. E., Poulton I. J., Solano M., Pompolo S., Fernandes T. J., Constable M. J., Nicholson G. C., Zhang J. G., Nicola N. A., Gillespie M. T., Martin T. J., Sims N. A. RT Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. RL J. Clin. Invest. 120:582-592 (2010). RN [16]; RE0067764. RX PUBMED: 16547273. RA Fritz D. K., Kerr C., Tong L., Smyth D., Richards C. D. RT Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6. RL J. Immunol. 176:4352-4360 (2006). RN [17]; RE0068007. RX PUBMED: 19651781. RA Wang X., Zhao Q., Matta R., Meng X., Liu X., Liu C. G., Nelin L. D., Liu Y. RT Inducible nitric-oxide synthase expression is regulated by mitogen-activated protein kinase phosphatase-1. RL J. Biol. Chem. 284:27123-27134 (2009). RN [18]; RE0068170. RX PUBMED: 17609432. RA Brender C., Tannahill G. M., Jenkins B. J., Fletcher J., Columbus R., Saris C. J., Ernst M., Nicola N. A., Hilton D. J., Alexander W. S., Starr R. RT Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. RL Blood 110:2528-2536 (2007). RN [19]; RE0068198. RX PUBMED: 17114427. RA Owaki T., Asakawa M., Fukai F., Mizuguchi J., Yoshimoto T. RT IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. RL J. Immunol. 177:7579-7587 (2006). RN [20]; RE0068301. RX PUBMED: 9711940. RA Kunisada K., Tone E., Fujio Y., Matsui H., Yamauchi-Takihara K., Kishimoto T. RT Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. RL Circulation 98:346-352 (1998). RN [21]; RE0068438. RX PUBMED: 16966486. RA Samardzija M., Wenzel A., Aufenberg S., Thiersch M., Reme C., Grimm C. RT Differential role of Jak-STAT signaling in retinal degenerations. RL FASEB J. 20:2411-2413 (2006). RN [22]; RE0069326. RX PUBMED: 20231379. RA Gotoh K., Tanaka Y., Nishikimi A., Nakamura R., Yamada H., Maeda N., Ishikawa T., Hoshino K., Uruno T., Cao Q., Higashi S., Kawaguchi Y., Enjoji M., Takayanagi R., Kaisho T., Yoshikai Y., Fukui Y. RT Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. RL J. Exp. Med. 207:721-730 (2010). RN [23]; RE0070678. RX PUBMED: 20531401. RA Weintz G., Olsen J. V., Fruhauf K., Niedzielska M., Amit I., Jantsch J., Mages J., Frech C., Dolken L., Mann M., Lang R. RT The phosphoproteome of toll-like receptor-activated macrophages. RL Mol. Syst. Biol. 6:371 (2010). XX //